◀ Back to MYLIP

ADAM9 — MYLIP

Text-mined interactions from Literome

Zhou et al., FEBS Lett 2011 (Carcinoma, Hepatocellular...) : MiR-1274a , which is up-regulated by sorafenib, could significantly repress expression of ADAM9 , a protease that is involved in sorafenib target-therapy of HCC, in HCC cells
Hamada et al., J Cell Physiol 2013 (Adenocarcinoma, Mucinous...) : We previously described that miR-126 is down-regulated in IDA compared with IPMA or IPMC, and miR-126 regulates the expression of invasion related molecule disintegrin and metalloproteinase domain containing protein 9 ( ADAM9 )